Evidence map›Paper›PMID 28359048›Full record

ArticleRedox biology2017

Inhibition of herpes simplex-1 virus replication by 25-hydroxycholesterol and 27-hydroxycholesterol.

Valeria Cagno, Andrea Civra, Daniela Rossin, Simone Calfapietra, Claudio Caccia, Valerio Leoni, Nicholas Dorma, Fiorella Biasi, Giuseppe Poli, David Lembo

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 57 citations in OpenAlex.

  1. Therapeutic Innovations for Monkeypox Inhibition.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Oxysterols in Infectious Diseases.Advances in experimental medicine and biology · 2024
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. 7-Ketocholesterol: Effects on viral infections and hypothetical contribution in COVID-19.The Journal of steroid biochemistry and molecular biology · 2021
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Valeria CagnoLaboratory of Molecular Virology and Antiviral Research. Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano, Torino, Italy.
Andrea CivraLaboratory of Molecular Virology and Antiviral Research. Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano, Torino, Italy.
Daniela RossinLaboratory of General Pathology. Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano, Torino, Italy.
Simone CalfapietraLaboratory of General Pathology. Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano, Torino, Italy.
Claudio CacciaLaboratory of Clinical Pathology and Molecular Medicine, Foundation IRCCS Institute of Neurology Carlo Besta, Milano, MI, Italy.
Valerio LeoniLaboratory of Clinical Chemistry, Hospital of Varese, ASST-Settelaghi, Varese, VA, Italy.
Nicholas DormaLaboratory of Molecular Virology and Antiviral Research. Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano, Torino, Italy.
Fiorella BiasiLaboratory of General Pathology. Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano, Torino, Italy.
Giuseppe PoliLaboratory of General Pathology. Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano, Torino, Italy. Electronic address: giuseppe.poli@unito.it.
David LemboLaboratory of Molecular Virology and Antiviral Research. Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano, Torino, Italy. Electronic address: david.lembo@unito.it.
University of Turin · ITFondazione IRCCS Istituto Neurologico Carlo Besta · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxysterols are known pleiotropic molecules whose antiviral action has been recently discovered. Here reported is the activity of a panel of oxysterols against HSV-1 with the identification of a new mechanism of action. A marked antiviral activity not only of 25HC but also of 27HC against HSV-1 was observed either if the oxysterols were added before or after infection, suggesting an activity unrelated to the viral entry inhibition as proposed by previous literature. Therefore, the relation between the pro-inflammatory activity of oxysterols and the activation of NF-kB and IL-6 induced by HSV-1 in the host cell was investigated. Indeed, cell pre-incubation with oxysterols further potentiated IL-6 production as induced by HSV-1 infection with a consequent boost of the interleukin's total cell secretion. Further, a direct antiviral effect of IL-6 administration to HSV-1 infected cells was demonstrated, disclosing an additional mechanism of antiviral action by both 25HC and 27HC.

Indexed as

AnimalsAntiviral AgentsChlorocebus aethiopsGene Expression RegulationHeLa CellsHerpes SimplexHerpesvirus 1, HumanHumansHydroxycholesterolsInterleukin-6NF-kappa BVero CellsVirus Replication25-hydroxycholesterol27-hydroxycholesterolAntiviral AgentsHydroxycholesterolsInterleukin-6NF-kappa B25-hydroxycholesterol27-hydroxycholesterolHerpes simplex-1Interleukin-6OxysterolsViral inhibition

Identifiers

PMID28359048
PMCPMC5374874
OpenAlexW2602781977

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.